Proceedings from the American Association for Cancer Research 2018 Annual Meeting

The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, and collaboration. As the largest scientific organization in the world that focuses on pioneering cancer research, it consistently and effectively stays true to this commitment, as evidenced by this year’s annual conference theme, Driving Innovative Cancer Science to Patient Care.

Oncology Times is pleased to report on the latest groundbreaking research presented at the AACR 2018 Annual Meeting, Chicago, IL.

Featured Articles

New! Evaluating Nivolumab + Ipilimumab vs. Standard Chemo in NSCLC

Lung cancer is the greatest cause of cancer death worldwide and for most patients with newly diagnosed advanced non-small cell lung cancer (NSCLC), chemotherapy has long been the standard.

Research Recap: Hot Topics From AACR Annual Meeting 2018

More than 22,500 attendees from over 70 countries came together in Chicago last week for the AACR Annual Meeting 2018.

Evaluating Chemotherapy & Pembrolizumab in Metastatic NSCLC

For patients having advanced non-small cell lung cancer (NSCLC) without any targetable mutations, the first-line therapy is platinum-based chemotherapy.

Precancerous Colon Polyps in Patients With Lynch Syndrome Exhibit Immune Activation

Colon polyps from patients with Lynch syndrome, a hereditary condition that raises colorectal cancer risk, display immune system activation well before cancer development, according to research from The University of Texas MD Anderson Cancer Center, Houston.

Follow us on
- Twitter
- Facebook
Resources
- Privacy Policy
- Terms of Use

Follow us on
- Twitter
- Facebook
Resources
- Privacy Policy
- Terms of Use

Contact Wolters Kluwer
customerservice@lww.com